Dr Sasha Bakhru says 108 BioCapital’s $20 million investment into Pinwheel Therapeutics will fund a Phase 2b trial of Ciraparantag, a late stage anticoagulant...
Dr Sasha Bakhru says 108 BioCapital’s $20 million investment into Pinwheel Therapeutics will fund a Phase 2b trial of Ciraparantag, a late stage anticoagulant...